2023
DOI: 10.1097/pcc.0000000000003141
|View full text |Cite
|
Sign up to set email alerts
|

The Classic Critical Care Conundrum Encounters Precision Medicine*

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 25 publications
0
3
0
Order By: Relevance
“…There is the 2013-−2017 life after pediatric sepsis evaluation (LAPSE) study that failed to identify an association between early corticosteroid therapy in children with septic shock and clinical and 1-month health-related quality of life outcomes (27, 28). There is also the 2015−2018 sepsis biomarker model (PERSEVERE)-II risk stratification study of pediatric septic shock, which had an opposite result to the LAPSE data and showed that corticosteroid administration was associated with increased mortality in a subgroup of children with high PERSEVERE-II risk score (29, 30). Hence, at present, we do not have a definitive answer about hydrocortisone.…”
Section: “Pccm Connections” For Readersmentioning
confidence: 99%
“…There is the 2013-−2017 life after pediatric sepsis evaluation (LAPSE) study that failed to identify an association between early corticosteroid therapy in children with septic shock and clinical and 1-month health-related quality of life outcomes (27, 28). There is also the 2015−2018 sepsis biomarker model (PERSEVERE)-II risk stratification study of pediatric septic shock, which had an opposite result to the LAPSE data and showed that corticosteroid administration was associated with increased mortality in a subgroup of children with high PERSEVERE-II risk score (29, 30). Hence, at present, we do not have a definitive answer about hydrocortisone.…”
Section: “Pccm Connections” For Readersmentioning
confidence: 99%
“…The authors use these data to encourage future research on phenotype, risk stratification, and trajectory in patients with sepsis. In fact, this information adds to two narratives about sepsis within PCCM: the Pediatric Sepsis Biomarker and Risk Model (PERSEVERE-II) and outcome data (21)(22)(23)(24); and the analysis of "trajectory" in time series data (25,26). (4).…”
Section: Atreya Mr Bennett Td Geva a Et Al; Novel Data-driven Sepsis ...mentioning
confidence: 99%
“…This could ultimately lead to more targeted and effective treatments for sepsis patients. While there is still much work to be done before transcriptomic data can be widely used in clinical settings, the research in this area is promising and could have significant implications for sepsis diagnosis and treatment in the future [ 5 , 6 , 7 , 8 , 9 ].…”
Section: Introductionmentioning
confidence: 99%